Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy M Albert

Showing results (211-220 of 342) with videos related to

Pageof 35
Sort By:
JACC. Advances|August 26, 2024
From Hospital to Home: Evidence-Based Care for Worsening Heart FailureSuzanne Oskouie, Ambarish Pandey, Andrew J Sauer, et al.
The American Journal of Cardiology|July 7, 2009
Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF)Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Circulation. Heart Failure|October 8, 2009
Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Journal of the American Heart Association|September 1, 2023
Association of SGLT-2 Inhibitors With Treatment Satisfaction and Diabetes-Specific and General Health Status in Adults With Cardiovascular Disease and Type 2 DiabetesQinglan Ding, Erica S Spatz, James F Bena, et al.
Journal of Cardiac Failure|November 13, 2007
Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HFGregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Journal of the American College of Cardiology|July 26, 2008
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)William T Abraham, Gregg C Fonarow, Nancy M Albert, et al.
The American Journal of Cardiology|November 26, 2008
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Circulation. Cardiovascular Quality and Outcomes|October 7, 2021
Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF RegistryAndy T Tran, Gregg C Fonarow, Suzanne V Arnold, et al.
Journal of the American College of Cardiology|July 12, 2008
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF programGregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Journal of the American College of Cardiology|August 21, 2007
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF RegistryGregg C Fonarow, Wendy Gattis Stough, William T Abraham, et al.
Pageof 35

Showing results (211-220 of 342) with videos related to

Sort By:
Pageof 35
JACC. Advances|August 26, 2024
From Hospital to Home: Evidence-Based Care for Worsening Heart FailureSuzanne Oskouie, Ambarish Pandey, Andrew J Sauer, et al.
The American Journal of Cardiology|July 7, 2009
Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF)Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Circulation. Heart Failure|October 8, 2009
Day of admission and clinical outcomes for patients hospitalized for heart failure: findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Journal of the American Heart Association|September 1, 2023
Association of SGLT-2 Inhibitors With Treatment Satisfaction and Diabetes-Specific and General Health Status in Adults With Cardiovascular Disease and Type 2 DiabetesQinglan Ding, Erica S Spatz, James F Bena, et al.
Journal of Cardiac Failure|November 13, 2007
Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HFGregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Journal of the American College of Cardiology|July 26, 2008
Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)William T Abraham, Gregg C Fonarow, Nancy M Albert, et al.
The American Journal of Cardiology|November 26, 2008
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Circulation. Cardiovascular Quality and Outcomes|October 7, 2021
Risk Adjustment Model for Preserved Health Status in Patients With Heart Failure and Reduced Ejection Fraction: The CHAMP-HF RegistryAndy T Tran, Gregg C Fonarow, Suzanne V Arnold, et al.
Journal of the American College of Cardiology|July 12, 2008
Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF programGregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Journal of the American College of Cardiology|August 21, 2007
Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF RegistryGregg C Fonarow, Wendy Gattis Stough, William T Abraham, et al.
Pageof 35